Johnson & Johnson's chief scientific officer, Dr. Paul Stoffels, talks rapid development of a COVID-19 vaccine and steps the company is taking to meet its 2021 deadline for an approved drug.
Johnson & Johnson Developing COVID-19 Vaccine, Expects Approval By Early 2021
Credit: Cheddar Inc.
Duration: 03:31s
0 shares
1 views